Back to Results
First PageMeta Content
Emerging technologies / Oxides / Nanotechnology / Nanomaterials / Nanoparticle / Nanotoxicology / Zinc oxide / Mesoporous material / Titanium dioxide / Chemistry / Materials science / Ultraviolet radiation


Microsoft Word - NANOMMUNE QHB_FINAL_2011
Add to Reading List

Document Date: 2014-03-06 07:08:43

Open Document

File Size: 926,63 KB

Share Result on Facebook

City

EMPA / Stockholm / /

Company

MATERIALS AND NEW PRODUCTION TECHNOLOGIES / Luminex / ENs / Sigma Aldrich / Donaldson / Krug HF / St. Gallen Switzerland / /

Continent

Europe / /

Country

Germany / Switzerland / United States / United Kingdom / Sweden / Finland / /

Currency

pence / /

Event

FDA Phase / Product Issues / Environmental Issue / /

IndustryTerm

grade solution / chemical reactivity / given physico-chemical parameter / read-out systems / physico-chemical properties / certain medical applications / biological systems / electronics / biological applications / physico-chemical characterization / manufacturing / nanoparticle solution / in vivo systems / physico-chemical attributes / experimental protocols / /

Organization

European Union / /

Person

NANOMMUNE QHB / Muhammed Strømme / Elga Purelab / Harald F. Krug / /

/

Position

Project Coordinator / Walker / representative / Workpackage Leader WP3 Editor / representative categories / /

Product

Folic acid / RNAlater® solution / EFFECTS / properties / /

Technology

NANOMMUNE 3.4v1 Protocol / DNA Chip / 3.28 Cytokine measurement using xMAP™ Technology / 1.2 SOP NANOMMUNE 5.2v1 Protocol / Spectroscopy / Transcriptomics / Microwave / 1.1 SOP NANOMMUNE 5.1v1 Protocol / 1.2 Scope This protocol / apoptosis / /

SocialTag